TB500/BPC157 5MG/5MG

TB-500 / BPC-157 5mg / 5mg

Dual-peptide research formulation studied for cellular repair signaling, actin regulation pathways, and regenerative tissue signaling models.

Compound Overview

TB-500 / BPC-157 is a dual-peptide research blend combining thymosin beta-4 analogue TB-500 with the pentadecapeptide BPC-157. This formulation is studied in laboratory environments for its interaction with signaling pathways involved in cellular repair, cytoskeletal regulation, and tissue regeneration research.

TB-500 is derived from thymosin beta-4 and is examined for its influence on actin-binding processes, cellular migration mechanisms, and angiogenic signaling pathways. BPC-157 is a peptide fragment originally derived from a protective gastric protein and is commonly studied for its interaction with nitric-oxide signaling systems, vascular communication pathways, and cellular repair signaling networks.

In experimental models, combined peptide systems such as TB-500 and BPC-157 are frequently evaluated for coordinated signaling across extracellular matrix remodeling pathways, endothelial communication systems, and cytoskeletal regulation processes associated with tissue regeneration research.

Product Specifications

• Product Name: TB-500 / BPC-157 Blend
• TB-500 Content: 5mg
• BPC-157 Content: 5mg
• Total Peptide Content: 10mg per vial
• Peptide Type: Regenerative signaling peptides
• Form: Lyophilized peptide blend
• Intended Use: Research use only